Precision Oncology & Diagnostics

Please click here to register

October 19-20,  2022 – Willis Tower, Chicago, IL

GenomeWeb and The Precision Medicine Leaders’ Summit present the

Precision Oncology and Diagnostics

as part of our comprehensive coverage of the Precision Medicine Continuum

An in-person and livestreamed event

Join us at the Precision Oncology and Diagnostics Summit to hear about the growing diversity and quality of precision medicine and targeted therapeutic offerings across the whole oncology spectrum. This in-person and live streamed event will take place October 19-20, 2022, at the Willis Tower in Chicago, IL.

Precision oncology had a tremendous boost with the 2015 roll-out of the Precision Medicine Initiative. What started with a focus on next-generation sequencing of the cancer genome has blossomed into a full set of tools for assaying solid and liquid tumors and the consequent development of analytical assays, analysis software platforms, and precision therapies—biologics, vaccines, and small-molecules.

Nowhere has precision oncology been more useful than in developing innovative technologies for understanding tumor heterogeneity. Precision oncology has benefited from, first, precision sequencing of populations of cells and, second, development of small-molecule drugs and biologics that alone or in combination have boosted the efficacy of therapies. Further, innovations in cell-based therapies (NK cell, CAR-T cell therapies) are increasingly in clinical use.

The advent of early detection technologies, liquid biopsies, MRD analyses, and other diagnostic technologies have enabled faster diagnosis, which is leading to more aggressive treatments earlier in patients’ treatment journey.

Please join us for the Precision Oncology & Diagnostics Summit to learn about this rapidly evolving market from leaders in biotech, pharmaceuticals, diagnostics, clinical research, healthcare, and regulatory bodies.

The Precision Oncology & Diagnostics Summit will gather a roster of experts to discuss the growing diversity and quality of oncology offerings in the precision medicine marketplace.

Topics to be discussed include:

  • Liquid Biopsy
  • Minimal Residual Disease (MRD)
  • Immuno-oncology
  • Molecular Tumor Boards
  • Combination Therapies
  • Early Detection of Cancer
  • Oncology Clinical Trials
  • Clinical Data in the Era of Precision Oncology
  • Biomarker/Genetics/Genomics Platforms
  • Clinical Decision Support
  • NGS for Oncology
  • Novel Therapies for Cancer
  • Pediatric Cancer
  • Antibody Drug Conjugates
  • Oncology Drug Development

plus many more…..

Additional Information Here